Surya Sankuratri

Developing engineered diabodies and antibody conjugates that activate or inhibit the targeted mechanism(s) specifically on relevant tissues, organs, and cells while exerting no significant activity on the non-targeted cells. EPOK Therapeutics’ focus disease areas include anemia and phosphate wasting disorders.